Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The FDA rolled out an updated system for members of the healthcare industry to meet with the agency about drug-related topics.
Here are the three latest drugs or medical devices approved by the FDA this week.
The FDA on Thursday approved NorthStar Medical Radioisotopes' RadioGenix System, which produces Technetium-99m — the most common radioisotope used in medical imaging.
A shortage of flu test kits is hitting health systems across central Indiana, reports Fox 59.
Device manufacturer Pentax voluntary recalled its ED-3490TK model duodenoscopes Wednesday, according to an FDA safety communication.
Intarcia Therapeutics, a biopharmaceutical company based in Boston, laid off 60 employees and terminated two late-stage trials of its lead diabetes treatment, reports the Boston Business Journal.
The College of Healthcare Information Management Executives penned a letter Feb. 6 to FDA Commissioner Scott Gottlieb, MD, to recommend the agency exempt certain health IT software from its oversight of clinical decision support solutions.
Supply chains stuck in traditional inventory management practices are fraught with high costs, waste and inefficiencies.
The FDA on Wednesday approved Gilead Sciences' HIV drug Biktarvy, reports Reuters.
Sanofi Genzyme will lay off 130 workers this week at its manufacturing plant in Boston in an effort to reduce costs and simplify operations, according to the Boston Globe.